Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Ducommun Inc. (NYSE: DCO) is well-positioned to capitalize on robust defense spending and a cyclical recovery in commercial aerospace. Despite a recent financial restatement related to historical stock-based compensation accounting, the company's underlying operational momentum remains strong. Ducommun is successfully executing its 'Vision 2027' strategy—targeting $950M to $1B in revenue and an 18% adjusted EBITDA margin—while shifting its portfolio toward higher-margin proprietary Engineered Products. The upcoming unveiling of its 'Vision 2032' strategy in September 2026 serves as a major catalyst to reset mid-term targets and highlight long-term capital allocation priorities.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets5 analysts · as of 18 Aug 2026
Low · most bearish analyst$200.00
Mean target$212.00
High · most bullish analyst$228.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario

The bear case reflects prolonged commercial aerospace supply chain disruptions, persistent destocking by major tier-1 customers, and delayed remediation of internal control weaknesses. These factors could lead to compressed margins and multiple contraction.

Base CaseCentral scenario

The base case assumes steady execution of the Vision 2027 roadmap, supported by a defense backlog of over $1.07B and commercial aerospace revenue growth in the mid-to-high single digits. Operational margins continue to expand through footprint consolidation (e.g., Monrovia facility closure) and a favorable product mix, offsetting near-term headwinds from supply chain destocking.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Strong defense backlog with over $1.07 billion in Remaining Performance Obligations (RPO), providing high revenue visibility.
  • Successful portfolio shift toward higher-margin proprietary Engineered Products, which reached 23% of revenue in 2025.
  • Clear operational roadmap with the upcoming 'Vision 2032' strategy launch on September 17, 2026, to drive long-term capital allocation.
  • Proven track record of margin expansion, with adjusted EBITDA margins rising to 16.4% in 2025.
Sign in / Sign up to read more
Key Investment Risks
  • Internal control weaknesses over financial reporting following the May 2026 restatement of 2024 and 2025 financial statements.
  • Exposure to commercial aerospace supply chain volatility and build-rate fluctuations from major OEMs like Boeing.
  • Customer concentration risks typical of the aerospace and defense sector.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Failure to successfully remediate material weaknesses in internal controls over financial reporting by late 2026.
  2. A significant downward revision of the Vision 2027 or newly introduced Vision 2032 financial targets during the September Investor Day.
  3. Severe production cuts or prolonged halts on key aircraft platforms (e.g., Boeing 737 MAX) that materially impact the Structural Systems segment.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.